Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is inflammatory myofibroblastic tumor?
Inflammatory myofibroblastic tumor (IMT) is a rare growth made of spindle-shaped 'myofibroblast' cells mixed with inflammatory immune cells. It is considered a borderline or low-grade cancer: it can grow into nearby tissue and occasionally spread, but it usually behaves in a much less aggressive way than typical cancers. It occurs most often in children, teenagers, and young adults, and can arise almost anywhere — the lung, abdomen, pelvis, and the soft tissues are common sites. Many IMTs are driven by a rearrangement of the ALK gene (or, less often, ROS1 or other genes), which produces an abnormal protein that fuels the tumor's growth. This discovery is important because it means many IMTs can be treated with targeted pills that block ALK, especially when surgery alone is not enough. Most IMTs are cured by complete surgical removal; radiation and targeted therapy are used for tumors that cannot be fully removed or that come back.
The main types
Doctors group inflammatory myofibroblastic tumor by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| ALK-positive | About half carry an ALK gene rearrangement; these can respond dramatically to ALK-blocking targeted pills, making them treatable even when surgery is difficult. |
| ALK-negative | Lack an ALK change; some instead have ROS1 or other gene rearrangements that may also be targetable, while others have no identified driver. |
| Epithelioid inflammatory myofibroblastic sarcoma | A rarer, more aggressive variant (often with a specific ALK pattern) that is more likely to spread and usually needs targeted therapy in addition to surgery. |
Staging, in plain terms
IMT does not have a standard cancer staging system. Instead, doctors describe whether the tumor can be completely removed, whether it has grown into nearby structures, and whether (rarely) it has spread. Its molecular profile — especially ALK status — guides treatment as much as its size.
| No formal TNM stage — described by extent and resectability | What it generally means |
|---|---|
| Localized, resectable | The tumor is confined and can be removed completely with surgery — the most common situation and usually curative. |
| Locally advanced / unresectable | The tumor has grown into structures that make complete removal unsafe or impossible; targeted therapy or radiation is used to control or shrink it. |
| Multifocal or metastatic | The tumor has spread to more than one site — uncommon; managed mainly with targeted therapy, especially when ALK-positive. |
| Recurrent | The tumor has returned after surgery; treated with repeat surgery, targeted therapy, or radiation depending on location and molecular profile. |
The standard of care
Inflammatory Myofibroblastic Tumor is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical removal
Surgery to remove the entire tumor is the main treatment and cures most patients when the tumor can be taken out with a clear margin.
Targeted therapy (ALK/ROS1 inhibitors)
For ALK-positive tumors that can't be fully removed, have spread, or come back, ALK-blocking pills such as crizotinib (and newer agents like lorlatinib) can shrink the tumor dramatically; ROS1 inhibitors help ROS1-driven tumors.
Radiation therapy
Radiation is used for tumors that cannot be completely removed, for close or positive surgical margins, or to control a tumor in a delicate location.
Molecular testing
Testing the tumor for ALK, ROS1, and other gene changes is essential, because it determines whether highly effective targeted pills can be used.
How radiation treatment works
Radiation damages the DNA inside tumor cells so they can no longer divide and survive, while healthy cells repair themselves more effectively. For inflammatory myofibroblastic tumor, radiation is used selectively — to treat tumors that cannot be fully removed, to clean up close surgical margins, or to control a tumor in a sensitive location. It is delivered as a series of short, painless daily sessions, uses no radioactive implants, and leaves no radioactivity in your body, so you remain safe to be around family and children. Because many of these tumors affect children, teams plan radiation carefully to protect growing tissue and often weigh targeted pills as an alternative.
The main ways radiation is delivered for inflammatory myofibroblastic tumor:
External-beam radiation (IMRT)
Computer-shaped beams treat the tumor or tumor bed while sparing nearby organs — useful when surgery would be disfiguring or incomplete.
Stereotactic radiation (SBRT/SRS)
Focused, high-dose radiation can precisely treat a tumor in a difficult location or a single site of recurrence while protecting surrounding tissue.
Radiation with targeted therapy
Radiation may be combined with or follow ALK-targeted pills to consolidate the response in tumors that cannot be removed.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
ALK inhibitors transform treatment: Trials and case series show that ALK-blocking targeted pills produce strong, durable responses in ALK-positive IMT, making them a standard option for tumors that cannot be removed or that have spread.[1]
Pediatric and adult IMT targeted-therapy studies (2021–2025)
Molecular profiling expands options: Beyond ALK, identifying ROS1, NTRK, and other gene fusions in IMT opens additional targeted treatments, reinforcing the value of routine molecular testing.[2]
Molecular pathology reviews (2022–2025)
Surgery remains curative for localized disease: Outcome studies confirm that complete surgical removal cures the majority of localized IMTs, with radiation and targeted therapy reserved for unresectable or recurrent tumors.[3]
Soft-tissue tumor outcome series (2022–2024)
Common questions
Is this really a cancer? IMT sits in a borderline category. It can grow into nearby tissue and, rarely, spread, so it is taken seriously and treated, but most IMTs behave far less aggressively than typical cancers and are cured by surgery.
What does 'ALK-positive' mean for my treatment? It means the tumor carries an ALK gene change that drives its growth. That is good news for treatment, because targeted pills that block ALK can shrink these tumors dramatically — a powerful option when surgery alone isn't enough.
Will it come back after surgery? Most completely removed IMTs do not return, but because they can recur locally, your team will follow you with periodic exams and imaging. If a tumor does come back, options include repeat surgery, targeted therapy, and radiation.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.